133 related articles for article (PubMed ID: 20542955)
1. Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase.
Chang JY; He RY; Lin HP; Hsu LJ; Lai FJ; Hong Q; Chen SJ; Chang NS
Exp Biol Med (Maywood); 2010 Jul; 235(7):796-804. PubMed ID: 20542955
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1.
Hsu LJ; Schultz L; Hong Q; Van Moer K; Heath J; Li MY; Lai FJ; Lin SR; Lee MH; Lo CP; Lin YS; Chen ST; Chang NS
J Biol Chem; 2009 Jun; 284(23):16049-59. PubMed ID: 19366691
[TBL] [Abstract][Full Text] [Related]
3. WWOX: its genomics, partners, and functions.
Del Mare S; Salah Z; Aqeilan RI
J Cell Biochem; 2009 Nov; 108(4):737-45. PubMed ID: 19708029
[TBL] [Abstract][Full Text] [Related]
4. WWOX in biological control and tumorigenesis.
Aqeilan RI; Croce CM
J Cell Physiol; 2007 Aug; 212(2):307-10. PubMed ID: 17458891
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cell signaling and apoptosis by tumor suppressor WWOX.
Lo JY; Chou YT; Lai FJ; Hsu LJ
Exp Biol Med (Maywood); 2015 Mar; 240(3):383-91. PubMed ID: 25595191
[TBL] [Abstract][Full Text] [Related]
6. A potential role of p53 and WOX1 in mitochondrial apoptosis (review).
Chang NS
Int J Mol Med; 2002 Jan; 9(1):19-24. PubMed ID: 11744990
[TBL] [Abstract][Full Text] [Related]
7. Introduction to a thematic issue for WWOX.
Chang NS
Exp Biol Med (Maywood); 2015 Mar; 240(3):281-4. PubMed ID: 25802472
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan activates Hyal-2/WWOX/Smad4 signaling and causes bubbling cell death when the signaling complex is overexpressed.
Hsu LJ; Hong Q; Chen ST; Kuo HL; Schultz L; Heath J; Lin SR; Lee MH; Li DZ; Li ZL; Cheng HC; Armand G; Chang NS
Oncotarget; 2017 Mar; 8(12):19137-19155. PubMed ID: 27845895
[TBL] [Abstract][Full Text] [Related]
9. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
[TBL] [Abstract][Full Text] [Related]
10. MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1.
Lo CP; Hsu LJ; Li MY; Hsu SY; Chuang JI; Tsai MS; Lin SR; Chang NS; Chen ST
Eur J Neurosci; 2008 Apr; 27(7):1634-46. PubMed ID: 18371080
[TBL] [Abstract][Full Text] [Related]
11. Wwox suppresses prostate cancer cell growth through modulation of ErbB2-mediated androgen receptor signaling.
Qin HR; Iliopoulos D; Nakamura T; Costinean S; Volinia S; Druck T; Sun J; Okumura H; Huebner K
Mol Cancer Res; 2007 Sep; 5(9):957-65. PubMed ID: 17704139
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity.
Chang NS; Pratt N; Heath J; Schultz L; Sleve D; Carey GB; Zevotek N
J Biol Chem; 2001 Feb; 276(5):3361-70. PubMed ID: 11058590
[TBL] [Abstract][Full Text] [Related]
14. Complement C1q activates tumor suppressor WWOX to induce apoptosis in prostate cancer cells.
Hong Q; Sze CI; Lin SR; Lee MH; He RY; Schultz L; Chang JY; Chen SJ; Boackle RJ; Hsu LJ; Chang NS
PLoS One; 2009 Jun; 4(6):e5755. PubMed ID: 19484134
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts.
Chang NS
BMC Cell Biol; 2002 Apr; 3():8. PubMed ID: 11960552
[TBL] [Abstract][Full Text] [Related]
16. Basement membrane component laminin-5 is a target of the tumor suppressor Smad4.
Zapatka M; Zboralski D; Radacz Y; Böckmann M; Arnold C; Schöneck A; Hoppe S; Tannapfel A; Schmiegel W; Simon-Assmann P; Schwarte-Waldhoff I
Oncogene; 2007 Mar; 26(10):1417-27. PubMed ID: 16953227
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the functional versatility of WW domain-containing oxidoreductase tumor suppressor.
Farooq A
Exp Biol Med (Maywood); 2015 Mar; 240(3):361-74. PubMed ID: 25662954
[TBL] [Abstract][Full Text] [Related]
18. 17beta-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo.
Chang NS; Schultz L; Hsu LJ; Lewis J; Su M; Sze CI
Oncogene; 2005 Jan; 24(4):714-23. PubMed ID: 15580310
[TBL] [Abstract][Full Text] [Related]
19. Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase.
Chang Y; Lan YY; Hsiao JR; Chang NS
Exp Biol Med (Maywood); 2015 Mar; 240(3):329-37. PubMed ID: 25488911
[TBL] [Abstract][Full Text] [Related]
20. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
